MAP1LC3A and chronic obstructive pulmonary disease: Furthermore, the ratio of LC3A/B II to LC3A/B I was significantly increased in both control and COPD cells; however, it had a stronger effect in COPD cells (control 133.4%, COPD 193.9%, Figure 4A).